Catalyst Wire Dossier Catalyst Wire Dossier

LPM3480392

· Luye Pharma Group Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LPM3480392, covering 2024-01-12 to 2024-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery [Phase 2]

See pricing